{"id":"W2599952659","doi":"10.1200/jco.2017.35.4_suppl.332","title":"A preclinical trial to evaluate therapies for <i>BRCA</i>-associated pancreatic cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; McGill University Health Centre; McGill University","funders":"","keywords":"Gemcitabine; Medicine; Cisplatin; PARP inhibitor; Pancreatic cancer; BRCA mutation; Internal medicine; Oncology; Cancer research; Combination therapy; Olaparib; Chemotherapy; Cancer; Pharmacology; Poly ADP ribose polymerase; Breast cancer; Polymerase; Biology; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119448,0.001320022,0.001137471,0.0004349683,0.0003179344,0.0008914801,0.0008412625,0.00160476,0.008362225],"category_scores_gemma":[0.0005829433,0.0003349836,0.0007160014,0.0003801934,0.0007136504,0.0007295625,0.0002856023,0.002558999,0.001549288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006461836,"about_ca_system_score_gemma":0.001626349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004426227,"about_ca_topic_score_gemma":0.001168319,"domain_scores_codex":[0.9997353,0.0001079667,0.00001261863,0.00004896504,0.00002825794,0.00006690379],"domain_scores_gemma":[0.9995136,0.00005951696,0.00009299233,0.00003700059,0.00003539967,0.0002615574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5874121,0.09416826,0.003661217,0.002427495,0.001031428,0.0005607233,0.0001878654,0.002995085,0.1381781,0.001918437,0.01202896,0.1554304],"study_design_scores_gemma":[0.3923272,0.5783895,0.00308479,0.0001195324,0.0003769018,0.0004519642,0.0000548596,0.001302866,0.01257861,0.0005514582,0.01073849,0.00002365642],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.963125,0.008365507,0.002363029,0.002337369,0.0005995479,0.009220352,0.003764308,0.0003379113,0.00988692],"genre_scores_gemma":[0.9621135,0.006322538,0.004409812,0.002239396,0.0003294586,0.009788669,0.005698599,0.00004025672,0.009057686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008362225,"threshold_uncertainty_score":0.02797449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2565038096556995,"score_gpt":0.5824217293881295,"score_spread":0.32591791973243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}